Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA
BMJ. 2016 Jan 20;532:h5918. doi: 10.1136/bmj.h5918.
Psychiatric conditions (including substance misuse disorders) are serious, potentially life threatening illnesses that can be successfully treated by psychotropic drugs, even during pregnancy. Because few rigorously designed prospective studies have examined the safety of these drugs during pregnancy, the default clinical recommendation has been to discontinue them, especially during the first trimester. However, in the past decade, as more evidence has accumulated, it seems that most psychotropic drugs are relatively safe to use in pregnancy and that not using them when indicated for serious psychiatric illness poses a greater risk to both mother and child, including tragic outcomes like suicide and infanticide. This review presents an up to date and careful examination of the most rigorous scientific studies on the effects of psychotropic drugs in pregnancy. The lack of evidence in several areas means that definite conclusions cannot be made about the risks and benefits of all psychotropic drug use in pregnancy.
精神疾病(包括物质使用障碍)是严重的、潜在威胁生命的疾病,可以通过精神药物成功治疗,即使在怀孕期间也是如此。由于很少有严格设计的前瞻性研究检查这些药物在怀孕期间的安全性,因此默认的临床建议是停止使用这些药物,尤其是在怀孕的前三个月。然而,在过去的十年中,随着更多证据的积累,似乎大多数精神药物在怀孕期间使用相对安全,而在严重精神疾病需要使用时不使用这些药物会给母亲和孩子带来更大的风险,包括自杀和杀婴等悲惨后果。这篇综述对精神药物在怀孕期间影响的最严格的科学研究进行了最新和仔细的检查。在几个领域缺乏证据意味着不能确定所有精神药物在怀孕期间使用的风险和益处。